Investor directory
Versant Ventures
Versant Ventures differentiates itself by leveraging scientific expertise and partnerships with academic institutions to create innovative biotech companies.
What they invest in
Sectors
Geographies
global
The facts
- Typical cheque
- €2M – €75M
- Headquarters
- Switzerland
- Founded
- 1999
Portfolio
Jade Biosciences (NAS: JBIO)CRISPR Therapeutics (NAS: CRSP)BlueRock TherapeuticsBorealis BiosciencesCapsida BiotherapeuticsChinook TherapeuticsAbdera TherapeuticsSixPeaks BioVectivBioBright Peak TherapeuticsCentury Therapeutics (NAS: IPSC)RayzeBioHalioLava TherapeuticsTurnstone BiologicsGraphite BioVividion TherapeuticsPassage Bio (NAS: PASG)Ventus TherapeuticsLight Horse TherapeuticsNexo TherapeuticsTentarix BiotherapeuticsLycia TherapeuticsBlack Diamond Therapeutics (NAS: BDTX)
and 26 more
Does Versant Ventures fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Versant Ventures? Tell us what to correct and we will update it — or ask us to remove the entry.